What We're Reading: Page 215
Industry reads hand-picked by our editors
Oct 10, 2019
Oct 09, 2019
-
STAT
The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?
-
Reuters
Cracks in Purdue's proposed opioid settlement as Arizona backs out
-
Regulatory Focus
EMA Staff Losses Tick Up as Workload Increases
-
Bloomberg Government
AbbVie, Bristol-Myers Among Patient Advocacy Groups' Big Backers
Oct 08, 2019
Oct 07, 2019
-
The New York Times
Nobel Prize in Medicine Awarded to 3 for Work on Cells
-
ProPublica
Pharmaceutical Companies Are Luring Mexicans Across the U.S. Border to Donate Blood Plasma
-
The Wall Street Journal
Biotech Has a Supply Problem
Oct 04, 2019
-
1843
Will there ever be a cure for chronic pain?
-
The Nevada Independent
Two dozen companies could be fined $20 million by state for noncompliance with diabetes drug transparency law
-
STAT
Congress just quietly passed a bill that will cost drug makers $3 billion
-
The New York Times
Why Lifesaving Drugs May Be Missing on Your Next Flight
Oct 03, 2019
Oct 02, 2019
-
BioCentury
Trump to nominate Hahn as FDA commissioner
-
Financial Times
Insulin maker Novo Nordisk walks moral tightrope
-
Los Angeles Times
FDA tried to ban vape flavors before crisis. Obama nixed the plan.
-
Vantage
Clovis is running out of waves to catch
Previous
